MMAP-11 VOLUMETRIC STUDY OF BRAIN METASTASES IN EGFR-POSITIVE NSCLC TREATED WITH OSIMERTINIB WITH OR WITHOUT CNS-DIRECTED RADIATION THERAPY

BACKGROUND: In patients with brain metastases (BM) from EGFR-positive non-small cell lung cancer (NSCLC), recent data indicated that treating with CNS-penetrant tyrosine kinase inhibitors such as osimertinib may enable deferring radiotherapy (RT) in select patients. The purpose of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Lisa, Phuong, Christina, Chen, Jie Jane, Chen, William, Daras, Mariza, Raleigh, David, Nakamura, Jean, Boreta, Lauren, Sneed, Penny, Braunstein, Steve
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354225/
http://dx.doi.org/10.1093/noajnl/vdac078.067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354225/
http://dx.doi.org/10.1093/noajnl/vdac078.067

Ejemplares similares